Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance
Open Access
- 1 June 2021
- journal article
- research article
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 10 (9), 711-731
- https://doi.org/10.2217/cer-2020-0228
Abstract
Decision-makers have become increasingly interested in incorporating real-world evidence (RWE) into their decision-making process. Due to concerns regarding the reliability and quality of RWE, stakeholders have issued numerous recommendation documents to assist in setting RWE standards. The fragmented nature of these documents poses a challenge to researchers and decision-makers looking for guidance on what is ‘high-quality’ RWE and how it can be used in decision-making. We offer researchers and decision-makers a structure to organize the landscape of RWE recommendations and identify consensus and gaps in the current recommendations. To provide researchers with a much needed pathway for generating RWE, we discuss how decision-makers can move from fragmented recommendations to comprehensive guidance.Keywords
This publication has 30 references indexed in Scilit:
- Standards and guidelines for observational studies: quality is in the eye of the beholderJournal of Clinical Epidemiology, 2015
- A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force ReportValue in Health, 2014
- Guidelines for good database selection and use in pharmacoepidemiology researchPharmacoepidemiology and Drug Safety, 2011
- Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part IIValue in Health, 2009
- Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part IIIValue in Health, 2009
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- In Defense of Pharmacoepidemiology — Embracing the Yin and Yang of Drug ResearchThe New England Journal of Medicine, 2007
- Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force ReportValue in Health, 2007
- Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeuticsPharmacoepidemiology and Drug Safety, 2006
- A Checklist for Retrospective Database Studies—Report of the ISPOR Task Force on Retrospective DatabasesValue in Health, 2003